rilpivirine news

All news on rilpivirine (also known as TMC278 and Edurant): plants, production capacities, investments and involved companies.

29 July 2026

ViiV Healthcare: Cabenuva superior to daily oral therapy in adolescents at AIDS 2026

LATA shows superiority in adolescents; OPERA real‑world suppression comparable to oral regimens; cabotegravir injections rated better than lenacapavir; EXTEND 4M tests 4‑month formulation.

Who will be producing rilpivirine in the future?

Find out with chemXplore Alpha

Learn more